ProShare Advisors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

ProShare Advisors’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-23,879	Closed	-$1.8M	–	1642
2015 Q2	$1.8M	Buy	23,879 +2,248	+10%	+$120K	0.02%	548
2015 Q1	$1.08M	Buy	21,631 +2,876	+15%	+$121K	0.01%	808
2014 Q4	$650K	Buy	18,755 +159	+0.9%	+$5.55K	0.01%	1081
2014 Q3	$609K	Sell	18,596 -3,638	-16%	-$128K	0.01%	1285
2014 Q2	$853K	Sell	22,234 -6,085	-21%	-$212K	0.01%	1244
2014 Q1	$1.13M	Buy	28,319 +18,116	+178%	+$810K	0.01%	1204
2013 Q4	$380K	Buy	10,203 +3,763	+58%	+$156K	0.01%	1109
2013 Q3	$294K	Buy	+6,440	New	+$193K	0.01%	1913

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

ProShare Advisors's KYTH Position: Q3 2015 in Review

ProShare Advisors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 23,879 shares — an estimated $1.8M sold.

ProShare Advisors first reported a position in KYTH in Q3 2013 and held it in 8 quarters. The position peaked at $1.8M in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

ProShare Advisors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
ProShare Advisors sold 23,879 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $1.8M.
ProShare Advisors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 8 quarters.
ProShare Advisors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.8M in Q2 2015.
143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on ProShare Advisors's 13F filing for Q3 2015, filed 6 Nov 2015.